TrialsgrambetaRCTs are beautiful

BLOCK-COPD

2019

Beta-Blockers for the Prevention of Acute Exacerbations of COPD

In 532 patients with moderate-to-severe COPD without cardiac indication for β-blockade, metoprolol succinate did not reduce time to first exacerbation and increased severe exacerbations compared with placebo.

Result

Efficacy: Time to first COPD exacerbationHR 1.05 · P = 0.66

Below 1 favours metoprolol succinate, above 1 favours placebo.

Also reported: Severe exacerbations HR 1.91 (95% CI 1.29–2.83).

Original publication
Subtopic
β-blocker safety
Design
Multicentre RCT, stopped early
Relevance
Important: one of several pillars.
Source
Dransfield MT, et al. N Engl J Med. 2019;381(24):2304-2314.doi 10.1056/NEJMoa1908142

Discussion & critique

Prophylactic β-blockade is harmful in COPD without a cardiac indication; informs cardiology co-management.